nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0438	0.055	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0324	0.0407	CcSEcCtD
Alfuzosin—Injury—Hydrochlorothiazide—nephrolithiasis	0.0256	0.0322	CcSEcCtD
Alfuzosin—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0248	0.0312	CcSEcCtD
Alfuzosin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0304	CcSEcCtD
Alfuzosin—ADRA1A—Endothelin Pathways—ADCY10—nephrolithiasis	0.0217	0.106	CbGpPWpGaD
Alfuzosin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0215	0.027	CcSEcCtD
Alfuzosin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.0215	0.027	CcSEcCtD
Alfuzosin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0213	0.0267	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0266	CcSEcCtD
Alfuzosin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0198	0.0249	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0189	0.0238	CcSEcCtD
Alfuzosin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.0187	0.0235	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0223	CcSEcCtD
Alfuzosin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0222	CcSEcCtD
Alfuzosin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0174	0.0218	CcSEcCtD
Alfuzosin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.017	0.0214	CcSEcCtD
Alfuzosin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0205	CcSEcCtD
Alfuzosin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0203	CcSEcCtD
Alfuzosin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0151	0.019	CcSEcCtD
Alfuzosin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0172	CcSEcCtD
Alfuzosin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0165	CcSEcCtD
Alfuzosin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0163	CcSEcCtD
Alfuzosin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0161	CcSEcCtD
Alfuzosin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0127	0.016	CcSEcCtD
Alfuzosin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0127	0.016	CcSEcCtD
Alfuzosin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0157	CcSEcCtD
Alfuzosin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0157	CcSEcCtD
Alfuzosin—ADRA1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0122	0.0597	CbGpPWpGaD
Alfuzosin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0152	CcSEcCtD
Alfuzosin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0152	CcSEcCtD
Alfuzosin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0119	0.015	CcSEcCtD
Alfuzosin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0148	CcSEcCtD
Alfuzosin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0145	CcSEcCtD
Alfuzosin—Shock—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0143	CcSEcCtD
Alfuzosin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0142	CcSEcCtD
Alfuzosin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0142	CcSEcCtD
Alfuzosin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0141	CcSEcCtD
Alfuzosin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0136	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0132	CcSEcCtD
Alfuzosin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0129	CcSEcCtD
Alfuzosin—ADRA1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0103	0.0501	CbGpPWpGaD
Alfuzosin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0128	CcSEcCtD
Alfuzosin—ADRA1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0101	0.0495	CbGpPWpGaD
Alfuzosin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0125	CcSEcCtD
Alfuzosin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00988	0.0124	CcSEcCtD
Alfuzosin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00988	0.0124	CcSEcCtD
Alfuzosin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00952	0.012	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00945	0.0119	CcSEcCtD
Alfuzosin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0115	CcSEcCtD
Alfuzosin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00914	0.0115	CcSEcCtD
Alfuzosin—ADRA1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00901	0.044	CbGpPWpGaD
Alfuzosin—ADRA1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00853	0.0416	CbGpPWpGaD
Alfuzosin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00829	0.0104	CcSEcCtD
Alfuzosin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00818	0.0103	CcSEcCtD
Alfuzosin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00995	CcSEcCtD
Alfuzosin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00961	CcSEcCtD
Alfuzosin—ADRA1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00757	0.037	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00749	0.0366	CbGpPWpGaD
Alfuzosin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00735	0.00924	CcSEcCtD
Alfuzosin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00729	0.00916	CcSEcCtD
Alfuzosin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00916	CcSEcCtD
Alfuzosin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00724	0.00911	CcSEcCtD
Alfuzosin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00687	0.00863	CcSEcCtD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00622	0.0304	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00552	0.027	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Other—CHRM3—nephrolithiasis	0.00543	0.0265	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00422	0.0206	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00377	0.0184	CbGpPWpGaD
Alfuzosin—ADRA1D—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00366	0.0179	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0035	0.0171	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00313	0.0153	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00311	0.0152	CbGpPWpGaD
Alfuzosin—ADRA1D—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00305	0.0149	CbGpPWpGaD
Alfuzosin—ADRA1B—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00304	0.0148	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00278	0.0136	CbGpPWpGaD
Alfuzosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00273	0.0133	CbGpPWpGaD
Alfuzosin—ADRA1A—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0027	0.0132	CbGpPWpGaD
Alfuzosin—ADRA1B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00253	0.0124	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00236	0.0115	CbGpPWpGaD
Alfuzosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00226	0.0111	CbGpPWpGaD
Alfuzosin—ADRA1A—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00225	0.011	CbGpPWpGaD
Alfuzosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00202	0.00986	CbGpPWpGaD
Alfuzosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00201	0.00982	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00196	0.00956	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00178	0.00869	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00174	0.00849	CbGpPWpGaD
Alfuzosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00168	0.00819	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00162	0.00789	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00154	0.00751	CbGpPWpGaD
Alfuzosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00149	0.00727	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00148	0.00721	CbGpPWpGaD
Alfuzosin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00148	0.00721	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR ligand binding—PTH—nephrolithiasis	0.00141	0.00687	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00134	0.00655	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00131	0.00641	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00128	0.00623	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.0012	0.00587	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00119	0.00582	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR ligand binding—PTH—nephrolithiasis	0.00117	0.0057	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.00113	0.00554	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ADCY10—nephrolithiasis	0.00112	0.00548	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—DGKH—nephrolithiasis	0.00109	0.00533	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	0.00104	0.00506	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000998	0.00487	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	0.000955	0.00466	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000932	0.00455	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000906	0.00443	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000887	0.00433	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000869	0.00424	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000828	0.00404	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000805	0.00393	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000795	0.00388	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	0.000793	0.00387	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.00079	0.00385	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	0.000722	0.00353	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000722	0.00352	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	0.000704	0.00344	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00066	0.00322	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000655	0.0032	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000645	0.00315	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	0.000645	0.00315	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000641	0.00313	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	0.000599	0.00293	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000586	0.00286	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000582	0.00284	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000535	0.00261	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	0.000535	0.00261	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	0.000532	0.0026	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	0.000476	0.00232	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000476	0.00232	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000466	0.00228	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	0.000427	0.00208	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000387	0.00189	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	0.000354	0.00173	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000344	0.00168	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000333	0.00163	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	0.000314	0.00154	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000297	0.00145	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000253	0.00123	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000253	0.00123	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	0.000214	0.00105	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.00018	0.000879	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	0.000178	0.000868	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000163	0.000795	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	0.000158	0.000771	CbGpPWpGaD
